![Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Image - Image of american, generics: 187803275 Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Image - Image of american, generics: 187803275](https://thumbs.dreamstime.com/b/kyiv-ukraine-may-gastroenterology-generic-drug-omeprazole-teva-box-closeup-white-teva-pharmaceuticals-american-israeli-187803275.jpg)
Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Image - Image of american, generics: 187803275
![$135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C. $135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C.](https://www.lawmbg.com/wp-content/uploads/2019/01/iStock-Pills.jpg)
$135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C.
![Israeli Pension Fund Manager Leads Class Action Against Teva Pharmaceuticals Over Price-Hike and Opioid Scandals | Courthouse News Service Israeli Pension Fund Manager Leads Class Action Against Teva Pharmaceuticals Over Price-Hike and Opioid Scandals | Courthouse News Service](https://www.courthousenews.com/wp-content/uploads/2019/08/drugmoney.jpg)
Israeli Pension Fund Manager Leads Class Action Against Teva Pharmaceuticals Over Price-Hike and Opioid Scandals | Courthouse News Service
![Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire](https://mms.businesswire.com/media/20210831005107/en/739014/22/teva_RGB_JPEG.jpg)
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
![Teva Pharmaceuticals sells its product Paragard for $1.1B while active lawsuits are being filed - DrugReport.com - Reporting on Dangerous Drugs, Defective Medical Devices & Harmful Products Teva Pharmaceuticals sells its product Paragard for $1.1B while active lawsuits are being filed - DrugReport.com - Reporting on Dangerous Drugs, Defective Medical Devices & Harmful Products](https://www.drugreport.com/wp-content/uploads/2020/06/teva-pharma-paragard.jpg)